Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Drugmakers Are Vying for a Multibillion-Dollar Market

TheMotleyFool

0 0

Drugmakers Are Vying for a Multibillion-Dollar Market

Autoimmune diseases, such as rheumatoid arthritis, atopic dermatitis, and psoriatic arthritis, offer a multibillion-dollar opportunity for JAK inhibitors. In this video from Motley Fool Live, recorded on March 22, Fool.com contributors Brian Orelli and Keith Speights discuss the JAK inhibitors under development and which ones might be the safest bet given the Food and Drug Administration's crackdown on the drug class.

Source Fool.com

Like: 0

GILD

Share